Immuron Stock Current Liabilities
| IMC Stock | 0.08 0 1.32% |
Immuron fundamentals help investors to digest information that contributes to Immuron's financial success or failures. It also enables traders to predict the movement of Immuron Stock. The fundamental analysis module provides a way to measure Immuron's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immuron stock.
Total Current Liabilities is likely to gain to about 2.8 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 139.8 K in 2024. Immuron | Current Liabilities |
Immuron Company Current Liabilities Analysis
Immuron's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Immuron Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Immuron has a Current Liabilities of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Immuron Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (1.41) % | ||||
| Operating Margin | (1.32) % | ||||
| Current Valuation | 6.07 M | ||||
| Shares Outstanding | 228 M | ||||
| Shares Owned By Insiders | 18.39 % | ||||
| Price To Book | 1.38 X | ||||
| Price To Sales | 3.58 X | ||||
| Revenue | 4.9 M | ||||
| Gross Profit | 1.74 M | ||||
| EBITDA | (6.19 M) | ||||
| Net Income | (6.94 M) | ||||
| Total Debt | 173.5 K | ||||
| Book Value Per Share | 0.06 X | ||||
| Cash Flow From Operations | (5.88 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 0.3 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 17.56 M | ||||
| Total Asset | 15.55 M | ||||
| Retained Earnings | (78.97 M) | ||||
| Working Capital | 12.03 M | ||||
| Net Asset | 15.55 M |
About Immuron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immuron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immuron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immuron based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Immuron Stock Analysis
When running Immuron's price analysis, check to measure Immuron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuron is operating at the current time. Most of Immuron's value examination focuses on studying past and present price action to predict the probability of Immuron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuron's price. Additionally, you may evaluate how the addition of Immuron to your portfolios can decrease your overall portfolio volatility.